Ezaki Glico : Summary of Consolidated Financial Results (Japanese Accounting Standards) for the Second Quarter of the Fiscal Year Ending December 31, 2020

[Notes of caution]

This document is an English translation of the Japanese original. In the event of any differences or inconsistencies between the Japanese and English versions, the Japanese language version shall take precedence.

		August 6, 2020
Summary of Consolidated Financial Results (Japanese Accounting Standards)
	for the Second Quarter of the Fiscal Year Ending December 31, 2020
Listed company name: Ezaki Glico Co., Ltd.	Listed stock exchange: Tokyo Stock Exchange
Securities Code: 2206	URL: https://www.glico.com/jp/

Representative: Katsuhisa Ezaki, President and CEO

Scheduled filing date of quarterly report: August 7, 2020

Scheduled commencement date of dividend payments: September 4, 2020

Preparation of explanatory materials for financial results: Yes

Holding of a briefing on financial results: Yes

(Amounts less than ¥ million are rounded down.)

1. Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2020 (January 1, 2020 to June 30, 2020)

1. Consolidated results of operations

(The percentages indicate year-on-year changes.)

		Net sales			Operating profit	Ordinary profit	Profit attributable to
				owners of parent
Six months ended		¥ million		%	¥ million	%	¥ million	%	¥ million	%
June 30, 2020		165,975		-	8,731	-	9,671	-	6,283	-
September 30, 2019		185,525		(0.2)	10,774	(16.3)	11,744	(20.1)	8,783	(11.6)
(Note) Comprehensive Income:	Six months ended June 30, 2020: ¥3,900 million [-%]
		Six months ended September 30, 2019: ¥6,939 million [(41.6)%]
		Earnings			Earnings
	per share (basic)		per share (diluted)
Six months ended		¥			¥
June 30, 2020		96.79			-
September 30, 2019		134.98			-

The Company changed its fiscal year end from March 31 to December 31 upon the resolution of "Partial Amendment of Articles of Incorporation" at the 114th Annual Shareholders Meeting held on June 25, 2019. Accordingly, because the consolidation period for the six months ended June 30, 2020 (from January 1, 2020 to June 30, 2020) differs with the previous consolidation period for the six months ended September 30, 2019 (from April 1, 2019 to September 30, 2019), changes from the previous corresponding period have not been provided.

Additionally, for the six months ended September 30, 2019 for the Company and subsidiaries with fiscal year ended March 31, the consolidation period was the six months from April 1, 2019 to September 30, 2019 and for subsidiaries with fiscal year ended December 31, the consolidation period was the six months from January 1, 2019 to June 30, 2019.

(2) Consolidated financial position

		Total assets	Net assets	Shareholders'
		equity ratio
		¥ million	¥ million	%
As of June 30, 2020		335,541	222,964	64.2
As of December 31, 2019		343,812	220,915	62.0
(Reference) Shareholders' equity:	As of June 30, 2020: ¥215,566 million
		As of December 31, 2019: ¥213,181 million

(Segment Information, etc.) [Segment Information]

1. Six months ended September 30, 2019 (April 1, 2019- September 30, 2019) 1. Information on net sales and profit or losses by reportable segment

										(Unit: ¥ million)
			Reportable Segment						Amounts
										indicated on
	Confec-						Others		Adjusted	quarterly
	tionaries			Food			Total	amount	consolidated
	Ice Cream	Dairy	Overseas	Subtotal	(Note) 1
	and Food-	Ingredients		(Note) 2	financial
	Products									statements
										(Note 3)
Net sales
Sales to third	43,647	55,350	45,634	5,723	25,275	175,632	9,892	185,525	-	185,525
parties
Inter-segment
sales and	325	67	5	107	-	506	2,720	3,227	(3,227)	-
transfers
Total	43,973	55,418	45,640	5,831	25,275	176,139	12,613	188,753	(3,227)	185,525
Segment profit	2,203	5,615	1,813	505	(125)	10,012	53	10,065	708	10,774
(Notes)

1. The "Other" category is a business segment not included in reporting segments, and includes the Health segment (includes former Sports Foods segment), Office Glico segment, and the Systems Maintenance & Development Business segment.
2. The adjusted amount of ¥708 million in segment profit or losses includes ¥1,025 million for the elimination of intersegment transactions and other adjustment amounts of negative ¥316 million in companywide expenses not allocated to any reporting segment.
3. The total amount for segment income is adjusted based on the operating profit recorded for quarterly consolidated financial statements.

2. Impairment losses on fixed assets and information concerning goodwill, etc., for each reporting segment. Omitted due to lack of significance.

1. Six months ended June 30, 2020 (January 1, 2020- June 30, 2020) 1. Information on net sales and profit or losses by reportable segment

										(Unit: ¥ million)
			Reportable Segment						Amounts
										indicated on
	Confec-						Others		Adjusted	quarterly
	tionaries			Food			Total	amount	consolidated
	Ice Cream	Dairy	Overseas	Subtotal	(Note) 1
	and Food-	Ingredients		(Note) 2	financial
	Products									statements
										(Note 3)
Net sales
Sales to third	44,323	42,734	41,541	4,909	23,739	157,248	8,727	165,975	-	165,975
parties
Inter-segment
sales and	327	29	4	112	-	474	4,085	4,559	(4,559)	-
transfers
Total	44,650	42,764	41,545	5,022	23,739	157,722	12,812	170,535	(4,559)	165,975
Segment profit	2,620	2,943	1,229	411	861	8,066	(217)	7,849	881	8,731

(Notes)

1. The "Other" category is a business segment not included in reporting segments, and includes the Health segment (includes

7

former Sports Foods segment), Office Glico segment, and the Systems Maintenance & Development Business segment.

1. The adjusted amount of ¥881 million in segment profit or losses includes ¥634 million for the elimination of intersegment transactions and other adjustment amounts of ¥247 million in companywide expenses not allocated to any reporting segment.
2. The total amount for segment profit is adjusted based on the operating profit recorded for quarterly consolidated financial statements.

2. Impairment losses on fixed assets and information concerning goodwill, etc., for each reporting segment. Not applicable.

8

Supplementary Information

For the Fiscal Year Ending December 31, 2020

Ezaki Glico Co.,Ltd.

- 1 -